Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry

INTRODUCTION: Phase III clinical trials of dexamethasone intravitreal implant for diabetic macular oedema (DMO) have reported significant improvements in visual acuity (VA). Studies evaluating the treatment of DMO in routine clinical practice provide data to identify areas that need improvement. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhandari, Sanjeeb, Gabrielle, Pierre-Henry, Nguyen, Vuong, Daien, Vincent, Viola, Francesco, Bougamha, Walid, Young, Stephanie, Romero-Nuñez, Barbara, Figueras-Roca, Marc, Zarranz-Ventura, Javier, Barthelmes, Daniel, Sararols, Laura, Gillies, Mark, Creuzot-Garcher, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927495/
https://www.ncbi.nlm.nih.gov/pubmed/35179714
http://dx.doi.org/10.1007/s40123-022-00473-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927495/
https://www.ncbi.nlm.nih.gov/pubmed/35179714
http://dx.doi.org/10.1007/s40123-022-00473-3

Ejemplares similares